Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 507

    2.

    Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.

    Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T; Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus.

    Diabetes Res Clin Pract. 2002 Jan;55(1):65-85.PMID: 11755481 [PubMed - indexed for MEDLINE]Related articles

    3.

    Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.

    Jesudason DR, Dunstan K, Leong D, Wittert GA.

    Diabetes Care. 2003 Feb;26(2):485-90.PMID: 12547886 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.

    Inoue K, Matsumoto M, Akimoto K.

    Diabet Med. 2008 Oct;25(10):1157-63.PMID: 19046193 [PubMed - indexed for MEDLINE]Related articles

    5.

    Screening for diabetes mellitus--a two-step approach in individuals with impaired fasting glucose improves detection of those at risk of complications.

    Tai ES, Lim SC, Tan BY, Chew SK, Heng D, Tan CE.

    Diabet Med. 2000 Nov;17(11):771-5.PMID: 11131101 [PubMed - indexed for MEDLINE]Related articles

    6.

    [ADA criteria undervalues the impact of diabetes in a high-risk Spanish population]

    Martín Luján F, Costa Pinel B, Donado-Mazarrón Romero A, Basora Gallisà T, Basora Gallisà J, Piñol Moreso JL; Grupo de Investigacion sobre intolerancia a la Glucosa (Reus-Tarragona).

    Aten Primaria. 2000 Nov 15;26(8):517-24. Spanish. PMID: 11149184 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?

    Sargeant LA, Boyne MS, Bennett FI, Forrester TE, Cooper RS, Wilks RJ.

    Rev Panam Salud Publica. 2004 Jul;16(1):35-42.PMID: 15333264 [PubMed - indexed for MEDLINE]Related articles

    9.

    A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.

    Narayan KM, Hanson RL, Pettitt DJ, Bennett PH, Knowler WC.

    Diabetes Care. 1996 Sep;19(9):972-8.PMID: 8875091 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.

    Adam JM, Tarigan NP.

    Acta Med Indones. 2004 Jan-Mar;36(1):3-7.PMID: 15931695 [PubMed - indexed for MEDLINE]Related articles

    11.

    [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital]

    Ryu S, Chang YS, Kim DI, Suh BS, Kim WS.

    J Prev Med Public Health. 2005 May;38(2):203-7. Korean. PMID: 16315759 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience.

    Colagiuri S, Hussain Z, Zimmet P, Cameron A, Shaw J; AusDiab.

    Diabetes Care. 2004 Feb;27(2):367-71.PMID: 14747215 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients.

    Davidson J, Koro C, Arondekar B, Lee BH, Fedder D.

    Clin Ther. 2008 Feb;30(2):287-93.PMID: 18343267 [PubMed - indexed for MEDLINE]Related articles

    14.

    Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.

    Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS.

    Diabetes Care. 1998 Aug;21(8):1221-5.PMID: 9702423 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.

    Mula-Abed WA, Al-Naemi AH.

    Saudi Med J. 2003 May;24(5):477-84.PMID: 12847621 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cost-effectiveness analysis of different screening procedures for type 2 diabetes: the KORA Survey 2000.

    Icks A, Haastert B, Gandjour A, John J, Löwel H, Holle R, Giani G, Rathmann W; KORA Study Group.

    Diabetes Care. 2004 Sep;27(9):2120-8.PMID: 15333472 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.

    Luis Bautista J, Bugos C, Dirnberger G, Atherton T.

    Clin Ther. 2003 Jan;25(1):194-209.PMID: 12637120 [PubMed - indexed for MEDLINE]Related articles

    18.

    Screening for type 2 diabetes: literature review and economic modelling.

    Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.

    Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. Review.PMID: 17462167 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.

    de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ.

    JAMA. 2001 Apr 25;285(16):2109-13.PMID: 11311100 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

    Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E; DESIR Study Group.

    Diabetes Care. 2006 Jul;29(7):1619-25.PMID: 16801588 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data